"GLAXOSMITHKLINE is among three companies to be fined for breaches of Medicines Australia’s Code of Conduct after the pharma giant used fictitious patient quotes to promote its fluticasone product, Seretide.
MA said in its July–September quarterly report that the Code of Conduct committee dealt with allegations by Mundipharma that GSK’s promotional material on Seretide was false and misleading.
The committee said that while publishing fictitious patient quotes is itself a breach of the code, GSK had exacerbated its breach by placing the statements in quote marks beside the image of a young woman.
“GSK had agreed during intercompany dialogue to make clear that the statements were not from real patients,” the committee said."
The committee said that while publishing fictitious patient quotes is itself a breach of the code, GSK had exacerbated its breach by placing the statements in quote marks beside the image of a young woman.
“GSK had agreed during intercompany dialogue to make clear that the statements were not from real patients,” the committee said."
Medical Observer,
False claims: Pharma companies fined
Warwick Stanley 3rd Nov 2014
